SPDR S&P Biotech ETF Rating

SPDR S&P Biotech ETF logo
$140.18 -3.94 (-2.73%)
Closing price 11/20/2026 04:10 PM Eastern
Extended Trading
$140.94 +0.76 (+0.54%)
As of 11/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SPDR S&P Biotech ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

XBI Aggregate Rating

Moderate Buy
2.67

Holdings in XBI have an aggregate rating of Moderate Buy based on 512 analyst ratings issued in the past year covering 25 companies (40.2% of the portfolio).

XBI Aggregate Price Target

$140.18
High Prediction$140.18
Average Prediction$140.18
Low Prediction$140.18

Holdings in XBI have an aggregate price target of $140.18 and a range of $140.18 to $140.18 covering 25 companies (40.2% of the portfolio).

XBI Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
Moderate Buy
19 Moderate Buy rating(s)
Hold
6 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by SPDR S&P Biotech ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 25 XBI Holdings

Weight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)View
Ratings
2.66%
Moderna, Inc. stock logo
MRNA
Moderna
$194.18
-2.6%
Hold$120.25 -38.1%25
1.3548 of 5 stars
1.78%
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$93.47
-4.3%
Moderate Buy$110.53 18.3%17
2.1943 of 5 stars
1.76%
Exelixis, Inc. stock logo
EXEL
Exelixis
$64.63
-1.8%
Hold$58.62 -9.3%17
2.1898 of 5 stars
1.74%
Biogen Inc. stock logo
BIIB
Biogen
$249.59
+1.0%
Moderate Buy$255.45 2.3%33
2.9174 of 5 stars
1.74%
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$63.34
-2.4%
Moderate Buy$63.00 -0.5%9
2.0382 of 5 stars
1.73%
Amgen Inc. stock logo
AMGN
Amgen
$435.52
-0.8%
Hold$428.62 -1.6%33
3.9086 of 5 stars
1.72%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$920.69
-0.3%
Moderate Buy$904.41 -1.8%31
3.7636 of 5 stars
1.70%
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$95.81
-1.8%
Moderate Buy$141.00 47.2%11
2.7177 of 5 stars
1.70%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$554.73
-0.8%
Moderate Buy$676.40 21.9%16
4.6432 of 5 stars
1.70%
AbbVie Inc. stock logo
ABBV
AbbVie
$286.19
+0.9%
Moderate Buy$299.62 4.7%29
3.763 of 5 stars
1.69%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$166.33
-0.1%
Moderate Buy$171.63 3.2%29
3.1904 of 5 stars
1.63%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$150.57
-3.8%
Moderate Buy$202.59 34.5%24
4.8901 of 5 stars
1.53%
Alkermes plc stock logo
ALKS
Alkermes
$44.94
-2.7%
Moderate Buy$55.73 24.0%17
2.2698 of 5 stars
1.52%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$76.03
-2.8%
Moderate Buy$104.42 37.3%22
2.836 of 5 stars
1.52%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$514.76
-1.1%
Moderate Buy$596.44 15.9%28
3.8149 of 5 stars
1.45%
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$300.43
-3.4%
Moderate Buy$660.50 119.9%22
3.1666 of 5 stars
1.45%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$38.60
-0.9%
Moderate Buy$46.82 21.3%14
2.5918 of 5 stars
1.42%
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$115.10
-3.6%
Moderate Buy$139.16 20.9%27
2.4423 of 5 stars
1.42%
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$103.23
-7.5%
Hold$133.92 29.7%12
2.6002 of 5 stars
1.41%
Incyte Corporation stock logo
INCY
Incyte
$114.63
-1.1%
Hold$134.38 17.2%25
3.3159 of 5 stars
1.40%
Natera, Inc. stock logo
NTRA
Natera
$273.08
-5.8%
Moderate Buy$396.93 45.4%23
2.8659 of 5 stars
1.39%
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$56.42
-3.3%
Moderate Buy$99.23 75.9%15
3.7876 of 5 stars
1.38%
Erasca, Inc. stock logo
ERAS
Erasca
$13.61
-4.3%
Moderate Buy$23.17 70.2%12
1.7184 of 5 stars
1.37%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$97.17
-0.7%
Moderate Buy$117.86 21.3%8
2.8881 of 5 stars
1.37%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$91.35
-1.8%
Hold$110.17 20.6%13
4.5201 of 5 stars

This page (NYSEARCA:XBI) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners